Literature DB >> 23668024

[Determination of plasma protein binding rate of arctiin and arctigenin with ultrafiltration].

Xue-Ying Han1, Wei Wang, Ri-Qiu Tan, De-Qiang Dou.   

Abstract

OBJECTIVE: To determine the plasma protein binding rate of arctiin and arctigenin.
METHOD: The ultrafiltration combined with HPLC was employed to determine the plasma protein binding rate of arctiin and arctigenin as well as rat plasma and healthy human plasma proteins. RESULT: The plasma protein binding rate of arctiin with rat plasma at the concentrations of 64. 29, 32.14, 16.07 mg x L(-1) were (71.2 +/- 2.0)%, (73.4 +/- 0.61)%, (78.2 +/- 1.9)%, respectively; while the plasma protein binding rate of arctiin with healthy human plasma at the above concentrations were (64.8 +/- 3.1)%, (64.5 +/- 2.5)%, (77.5 +/- 1.7)%, respectively. The plasma protein binding rate of arctigenin with rat plasma at the concentrations of 77.42, 38.71, 19.36 mg x L(-1) were (96.7 +/- 0.41)%, (96.8 +/- 1.6)%, (97.3 +/- 0.46)%, respectively; while the plasma protein binding rate of arctigenin with normal human plasma at the above concentrations were (94.7 +/- 3.1)%, (96.8 +/- 1.6)%, (97.9 +/- 1.3)%, respectively.
CONCLUSION: The binding rate of arctiin with rat plasma protein was moderate, which is slightly higher than the binding rate of arctiin with healthy human plasma protein. The plasma protein binding rates of arctigenin with both rat plasma and healthy human plasma are very high.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23668024

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Huangzhi Oral Liquid Prevents Arrhythmias by Upregulating Caspase-3 and Apoptosis Network Proteins in Myocardial Ischemia-Reperfusion Injury in Rats.

Authors:  Xu Ran; Jian Xin Diao; Xue Gang Sun; Ming Wang; Hui An; Guo Qiang Huang; Xiao Shan Zhao; Wen Xiao Ma; Feng Hua Zhou; Yun Gao Yang; Can Ming Miao
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

2.  Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic.

Authors:  Juan Liao; Meiting Li; Chaoli Huang; Yan Yu; Yashu Chen; Jiaqi Gan; Jie Xiao; Guilin Xiang; Xizhi Ding; Rong Jiang; Peng Li; Mengchang Yang
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.